What happened: The 503B Bulks List proposal On April 30, 2026, the FDA announced it is proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List
But you do not need to have a diabetes to use a GLP-1 for weight loss
The secretion of immune cytokines primarily manifests the activation of macrophages
SR-BI is also the receptor, on the surface of hepatocytes, for HDL
Glutathione is present in every cell of our body and can help reduce free radicals, support detoxification in our bodies, and improve the overall health of our cells
Montgomery County Circuit Judge Monet Gaines denied ByteDances motion, allowing the States negligence, wantonness, and Deceptive Trade Practices Act claims to proceed